Our Team

Oliver T. Moses serves as the Managing Partner of WindRose Health Investors and has spent the last 27 years as a healthcare industry investor and advisor. Prior to joining WindRose in 2006, Mr. Moses was a Director of Merrill Lynch’s healthcare investment banking group where he was responsible for advising leading healthcare companies on mergers, acquisitions, and capital structure strategies. Mr. Moses began his career at Merrill Lynch in 1994, and prior to joining the investment banking team, he was a healthcare-focused securities analyst in Merrill Lynch’s equity research department.

Mr. Moses currently serves on the board of directors of MDsave, Shearwater Health, StateServ, Trumpet Behavioral Health, Healthmap Solutions and Workplace Options. Outside of his professional work, Mr. Moses is the Chairman and Founder of Haven Care, a health center that provides free healthcare to children in Liberia. He also serves as an elder of The Brick Presbyterian Church. He lives in New York City with his wife and two children.

Mr. Moses holds a Bachelor of Arts degree from Bowdoin College.

Alex Buzik is a Partner at WindRose Health Investors and has more than 19 years of experience in healthcare private equity and investment banking. Mr. Buzik is responsible for sourcing, executing and managing healthcare private equity investments at WindRose Health Investors. Prior to joining WindRose in 2005, Mr. Buzik worked as member of the Investment Banking Division at Lehman Brothers, where he focused on mergers and acquisitions as well as capital financings within the healthcare industry. Mr. Buzik currently serves on the board of directors of Kolmac, Traditions Behavioral Health, Curation Health, Accuity Delivery Systems and Bluestone. Mr. Buzik formerly served on the board of directors of Aerocare Holdings, Data Driven Delivery Systems, DNA Diagnostics Center, Florida Gulf-to-Bay Anesthesiology, HealthHelp, Ovation Fertility, and Woodbury Health Products.

Mr. Buzik received his Masters of Business Administration from The Wharton School at the University of Pennsylvania (majoring in Finance and Health Care Management) and his Bachelor of Arts in Biochemistry from Dartmouth College.

Mr. Burnes is a Partner at WindRose Health Investors. Prior to joining WindRose Health Investors in 2011, Mr. Burnes worked at Welsh, Carson, Anderson & Stowe where he evaluated and executed investment opportunities in the healthcare and business service sectors. Previously, Mr. Burnes worked in the Investment Banking Division at Bank of America, where he focused on financial sponsor and leveraged finance transactions. Mr. Burnes received an M.B.A. from Columbia Business School and B.A. from Connecticut College.

Mr. Burnes currently serves on the board of directors of Caregiver Inc., Lykan Bioscience, Trumpet Behavioral Health, Terrapin Pharmacy, Veristat, RevHealth, and BPD. Mr. Burnes formerly served on the board of directors of avadyne Health, basys, Celerion, myNEXUS, Secura Home Health, Medical Knowledge Group, Senior Home Care, and Vital Decisions.

Mr. Pontius received his Bachelor of Science in Business Administration from The University of North Carolina at Chapel Hill. Prior to joining WindRose Health Investors in 2008, Mr. Pontius worked in the Healthcare Investment Banking Group of Oppenheimer & Co. (formerly CIBC World Markets), where he focused on strategic advisory, mergers and acquisitions and public and private company financings. Mr. Pontius currently serves on the board of directors of MDsave,  Shearwater Health, Traditions Behavioral Health, Healthmap Solutions and Workplace Options.

Mr. Hall is a Principal at WindRose Health Investors.  Prior to joining WindRose Health Investors in 2018, Mr. Hall worked at Welsh, Carson, Anderson & Stowe (WCAS) where he was involved in all aspects of the investment process, focusing on the healthcare and technology sectors. Prior to WCAS, he was at Moelis Capital Partners, where he pursued private equity investments in the healthcare, software and business services sectors. Earlier, he worked in investment banking in Houlihan Lokey’s Industrials Group.  Mr. Hall graduated from the University of North Carolina Wilmington with a B.S. in business administration and received an M.S. in accountancy from Wake Forest University. He is a CFA charterholder. Mr. Hall currently serves on the board of directors of Bluestone, Caregiver Inc., Kolmac and Veristat.

Mr. Masterman is a Vice President at WindRose Health Investors.  Prior to joining WindRose Health Investors in 2021, Mr. Masterman worked at Silver Oak Services Partners where he evaluated and executed investment opportunities in the healthcare and business service sectors.  Prior to Silver Oak, he was at Brown Brothers Harriman Capital Partners, where he pursued private equity investments in the healthcare, technology and business services sectors.  Mr. Masterman received an M.B.A. from the University of Chicago Booth School of Business and B.A. from Amherst College. Mr. Masterman currently serves on the board of directors of Terrapin Pharmacy.

Mr. Stark is a Vice President at WindRose Health Investors. Prior to joining WindRose Health Investors in 2016, Mr. Stark worked at UBS Investment Bank in the Leveraged Finance & Financial Sponsors Group, where he focused on leveraged buyouts, restructurings, recapitalizations, and capital markets across a range of industries. Mr. Stark received his Bachelor of Arts in Economics and French from Williams College.

Mr. Stark currently serves on the board of directors of Healthmap Solutions, Shearwater Health, Trumpet Behavioral Health, Workplace Options, and BPD. Mr. Stark also works closely with Traditions Behavioral Health and Caregiver Inc., and was formerly involved in WindRose’s investments in AGS Health, Avadyne Health, and Woodbury Health Products.

Ms. Melocik is a Vice President at Windrose Health Investors. Prior to joining WindRose Health Investors in 2017, Ms. Melocik was an analyst at Wells Fargo Securities in the Mergers & Acquisitions Group, where she focused on a broad range of advisory transactions across various industries. Ms. Melocik graduated from the University of Florida with a Bachelor of Science in Finance and Master of Science in Finance. Ms. Melocik currently serves on the board of directors of basys, Curation Health, and Lykan Bioscience.

Prior to joining WindRose Health Investors in 2021, Mr. Nwafor was an analyst in the Healthcare Investment Banking Group at William Blair & Co., where he focused on mergers & acquisitions, leveraged finance and capital markets transactions in the healthcare services, healthcare IT, life sciences and medical devices industries. Mr. Nwafor received his Bachelor of Science in Biology from Tufts University.

Prior to joining WindRose Health Investors in 2021, Mr. Dolan was an Analyst in the Healthcare Investment Banking group at Deutsche Bank, where he focused on a variety of strategic acquisitions, leveraged buyouts and capital raises. Mr. Dolan graduated from Boston College with a Bachelor of Science in Finance.

Prior to joining WindRose Health Investors in 2021, Mr. Faso worked in healthcare investment banking at Cain Brothers, where he focused on strategic acquisitions, joint ventures, and capital raises in the healthcare industry. Before joining Cain Brothers, Mr. Faso worked in technology investment banking at Shea & Company, where he focused on mergers, acquisitions, and capital financings in the software industry. Mr. Faso received his Bachelor of Science in Business Administration with concentrations in Finance, Accounting, and Real Estate from Boston University Questrom School of Business.

Prior to joining WindRose Health Investors in 2022, Mr. McKibben was an Associate at Enhanced Healthcare Partners. Prior to joining Enhanced, Mr. McKibben was an Analyst in the Healthcare Investment Banking Group at Deutsche Bank, where he focused on M&A as well as equity and debt financing transactions. Prior to his role in Investment Banking, Mr. McKibben worked as an Associate for Best Merchant Partners. Mr. McKibben received a Bachelor of Business Administration in Finance from the University of Texas at Austin.

Prior to joining WindRose Health Investors in 2022, Mr. Applegate was an Analyst in the Healthcare Investment Banking Group at Deutsche Bank, where he focused on M&A, equity & debt financings and strategic advisory. Mr. Applegate received a Bachelor of Business Administration in Finance from Villanova University.

Ms. Coleman serves as the Head of Investor Relations at WindRose Health Investors. Prior to joining in 2021, Ms. Coleman worked at Court Square Capital where she focused on fundraising and investor relation efforts. Ms. Coleman started her career at PricewaterhouseCoopers in New York.

Ms. Coleman received a Master of Science in Accounting and a B.B.A. from the Cox School of Business at Southern Methodist University.

Mr. Spiciarich is the Chief Financial Officer and Chief Compliance Officer at WindRose Health Investors. After graduating from The Johns Hopkins University in 2005 with a B.A. in Political Science, he worked for over five years at Vastardis Capital. From there, Mr. Spiciarich moved to Magnitude Capital, a fund of funds, where he worked for over six years on both the fund and corporate sides of the business.

Ms. Myers serves as the Director of Finance responsible for fund administration of our portfolio of funds.  Prior to joining WindRose Health Investors in 2004, Ms. Myers was a Vice President at Goldman Sachs for seven years where she managed a group of 15 in financial reporting and tax compliance for the firm’s private equity funds and related employee funds.  Prior to Goldman Sachs, she was a Senior Manager at PwC providing attestation services to a broad group of private equity and mutual fund clients.  Ms. Myers is a former CPA and graduated from Michigan State University with a Bachelor of Arts in Accounting.

Prior to joining WindRose Health Investors in 2022, Mr. Gill was an Associate at iCapital, a financial technology platform offering alternative investments to investors, advisors, and asset managers. He was on the Private Equity Fund Finance team, managing a variety of private equity funds that are on their portal. Before joining iCapital, Mr. Gill was an Assurance Senior at Ernst & Young in Philadelphia. Working in Financial Services, Mr. Gill performed auditing procedures for many wealth and asset management clients, including private equity, SEC registered mutual funds, and unregistered funds. Mr. Gill has a Bachelor of Science in Business Administration with a major in Accounting from Saint Joseph’s University’s Haub School of Business.

Ms. Larocque has supported the Private Equity team since joining WindRose Health Investors in 2017. Prior to joining WindRose, she provided administrative support at the tech firm Catchpoint Systems, event coordination for speaker’s bureau Greater Talent Network, and Flying Television, a talent booking and brokering firm. Ms. Larocque received her Bachelor of Arts in Elementary Education from Endicott College in Beverly, MA.

Ms. Leonard joined WindRose Health Investors in 2018. Prior to joining WindRose she was with Aroya Capital, LP, RBC Capital Markets and Carlin Financial Group heading up areas including administrative services, internal operational structure and business integration.  Prior to joining Carlin Financial Group in New York, Ms. Leonard worked for Dain Rauscher in Dallas, Texas.  Ms. Leonard received her Master’s Degree from the University of Hartford and her Bachelor’s Degree from the University of North Texas.

Ms. Comens joined Windrose Health Investors in 2022. Prior to joining Windrose, she was a Producer and Executive Assistant at R/GA Advertising Agency, an Operations Analyst at Estée Lauder and Marketing Associate at Kiehl’s. Ms. Comens received her Bachelor of Science in Mathematics and Marketing at SUNY New Paltz.

Cherrill Farnsworth is an influential national expert on health care change and an entrepreneur who has started seven successful companies over the course of her career. Nationally recognized for her achievements, she has received the KPMG Peat Marwick High Tech Entrepreneur of the Year Award and the Ernst & Young Entrepreneur of the Year Award. The National Association of Specialty Health Organizations has named her “Most Influential in Specialty Health.”

Houston named her a Woman on the Move as early in her career as 1986. In 2015, she was elected to the prestigious Committee of 200, a membership organization of the world’s most successful women entrepreneurs and corporate innovators. Also, Farnsworth is an active elected member of the Women Business Leaders of the U.S. Health Care Industry Foundation.

Ms. Farnsworth is a regular speaker at business and health care symposia. Since 1984, Ms. Farnsworth has been a regular spokesperson before the Medicare Payment Advisory Commission (MedPAC) and the Centers for Medicare and Medicaid Services (CMS). She has testified on the need to regulate quality in radiology at the House Ways & Means Committee and Congress. She is also a member of the National Quality Forum (NQF), which was formed by the U.S. Senate in response to the Institute of Medicine’s report on medical mistakes.

Dr. Matt Brubaker is Chief Executive Officer of FMG Leading, a human capital advisory firm that creates world-class organizations at the intersection of humanity and high-performance.  He has over 25 years of experience, with a particular expertise in health care and private equity executive leadership development, conflict resolution, pre-acquisition organizational assessment, and post-acquisition culture integration and strategy design. Dr. Brubaker’s client list includes a broad range of industry-leading organizations, including The Children’s Hospital of Philadelphia, Deloitte, CNN, TeamHealth, Massachusetts General Hospital, Hackensack University Medical Center, Alliance HealthCare Services, Bristol-Myers Squibb, Chevron, DaVita, Janus, and Microsoft. A recognized thought leader on the subject of human capital strategy, his work has been published in Harvard Business Review, Forbes, Chief Executive Magazine, Fast Company, and Private Equity International. Dr. Brubaker earned his Master of Arts degree in Dispute Resolution at the University of Massachusetts, and his Doctor of Education in Organizational Change (Ed.D.) degree from Pepperdine University’s Graduate School of Education and Psychology. He currently resides outside of Philadelphia, Pennsylvania with his family.

Chuck Byrge is the CEO and President of Harpeth Capital. Mr. Byrge directs Harpeth Capital’s investment banking, venture capital and fund placement business. He has more than 28 years of experience with capital raising and M&A transactions for middle market companies.

Prior to joining Harpeth Capital, he was a Senior Managing Director and Head of Investment Banking at FTN Financial Securities, the investment banking arm of First Tennessee Bank (NYSE:FHN), where he was involved in opening and directing the New York and Nashville offices. Prior to that, he was Managing Director and Co-Head of Mergers and Acquisitions at SunTrust Equitable Securities (now SunTrust Robinson Humphrey), where he was responsible for directing a wide variety of assignments for both public and private companies. Previously, Chuck was a senior member of the Mergers and Acquisitions Department at Morgan Keegan & Co and a Vice President at NationsBanc Capital Markets in Dallas, Texas where he co-directed the M&A practice for the Southwestern U.S.

Chuck received a BA in Economics from Vanderbilt University and an MBA from the Owen Graduate School of Management at Vanderbilt University. Chuck is a Chartered Financial Analyst and a former Certified Public Accountant with Peat Marwick and Ernst & Young.

Chuck currently serves on the Entrepreneurship Advisory Council of Vanderbilt University’s Center for Technology Transfer and Commercialization and the Nashville Healthcare Council’s Fellows Alumni Board. Previously he has served on the Board of the Nashville Healthcare Council and as a Director of NextGxDx. He recently served on the Owen Graduate School of Management Alumni Board of Directors and is a former Board member of the Boy Scouts of America Middle Tennessee Council and the Nashville Sports Council.

Peter Crowley joined WindRose Health Investors in 2011 as an Operating Partner. Mr. Crowley retired from CIBC World Markets in April of 2008. Mr. Crowley spent 23 years at CIBC World Markets, the last fourteen as global head of healthcare investment banking. As global head of healthcare Mr. Crowley was involved in over five hundred transactions and over $30 billion of capital raised and transactions consummated. Transactions include public and private equity and debt financing’s and mergers and acquisitions transactions for biotechnology, pharmaceutical, medical devices, healthcare services and healthcare technology companies. Mr. Crowley was also heavily involved with the healthcare principal investments made by CIBC Capital Partners. Prior to CIBC Mr. Crowley worked for Allen & Company in venture capital and Blyth Eastman Paine Webber in mergers and acquisitions.

Mr. Crowley is a board member of the Foundation Fighting Blindness. He is also on the board of the following private companies: Anabios, Shearwater, Lykan Bioscience, and Veristat. He is a committee member of the Harvard Alumni Association and member of the council of Rockefeller University. He is also an Operating Partner at JH Partners, a consumer focused private equity fund with close to $1 Billion under management.

Mr. Crowley graduated from Harvard College in 1981 and received an M.B.A. from Columbia University in 1985.

Throughout his career, Mr. Daitz has distinguished himself as an architect and builder of organizations focused on bringing innovative healthcare services to the marketplace. He currently serves on the Board, and as an advisor to, three technology-enabled healthcare services businesses, Bluestone Physician Group, Workplace Options, and Cosan LLC.

Previously, Mr. Daitz was Co-founder, CEO and Executive Chairman of Vital Decisions, an organization dedicated to ensuring that the care of individuals experiencing a serious illness aligns with their values and changing preferences throughout every step of their health journey. Prior to Vital Decisions, he was co-founder and CEO of IntrinsiQ Research, a leading oncology electronic medical record and information company acquired by a private equity firm in 2006 and now a business unit of Amerisource Bergen. He was also the President of Datamonitor, Inc., an international healthcare market advisory firm, and management consultant with Deloitte Consulting. Mr. Daitz holds an engineering degree from Rutgers University and an MBA from the Wharton School of the University of Pennsylvania.

WindRose Operating Partner David Gibson has over 35 years of executive, private equity, professional services, and board experience.   Mr. Gibson has been working as an Operating Partner since 2010.  His work with WindRose has been in many areas, ranging from portfolio company board chair and member, executive management, strategic advisory and transaction preparation and execution.  Previously, Mr. Gibson spent nine years with Gibson & Rechan, LLC, an interim management and restructuring advisory firm he co-founded.  Before that, he spent eleven years with Alvarez & Marsal, Inc. where he was a Managing Director and provided executive management and company advisory services. He began his career with Arthur Andersen & Company where he was a Manager and CPA and provided M&A due diligence and audit services. He graduated from New York University with a Master of Arts in Economics and the University of Massachusetts with a Bachelor of Business Administration.

Michael Hammond has focused on the healthcare services industry for over 35 years. During this time, Mr. Hammond has advised many leading healthcare companies in the development of turnaround and reorganization strategies. Among his many clients, he has completed engagements recently for Catholic Health Initiatives (CO), Cedars-Sinai Medical Center (CA), Children’s Hospital Los Angeles, Geisinger Health System (PA), John Muir Health (CA) Sutter Health (CA), Texas Health Resources, Trinity Health (MI), Virginia Mason Medical Center (WA), and Barnabas Health (NJ).

Prior to the formation of H2C, Mr. Hammond was a founder of Shattuck Hammond Partners Inc. in 1993, a member of the board and management committees, and served as the President and CEO of PricewaterhouseCoopers Securities when Shattuck Hammond was owned by PWC (Shattuck Hammond was sold to Morgan Keegan & Company, Inc. in 2007). Prior to co-founding Shattuck Hammond Partners, Mr. Hammond managed the healthcare investment banking businesses at Salomon Brothers and Morgan Stanley, and was a Principal at Cain Brothers, Shattuck & Company.  Prior to joining Salomon Brothers in 1978, Mr. Hammond practiced law at Brown and Wood.

Mr. Vallarino has more than 35 years of experience in the health care industry. He has held key management roles in various sectors of the industry, physician practice management, institutional providers, and health care insurance companies, as well as his own consulting practice.

Mr. Vallarino spent 21 years with HCA and its predecessor companies. Most recently he served as Vice President of Employer & Payer Engagement for HCA with responsibility for over $30 billion in net revenues. During his tenure with HCA, he has held positions in Government Programs Compliance, Home Health Services and Physician Management Services. Prior to HCA, Mr. Vallarino served as Senior Vice President of Development for FPA Medical Management.

Mr. Vallarino last served as Chief Executive Officer of myNEXUS, having previously served the company in a Vice Chairman and a strategic advisor role since its inception. In April of 2021, he oversaw the successful sale of the company to Anthem Blue Cross Blue Shield. He currently serves on the various board including North American Partners in Anesthesia, Trumpet Behavioral Health and Brave Health and serves as a strategic advisor to several other healthcare companies. Mr. Vallarino also serves on the Board of the Grameen Foundation, a globally renowned organization focus on addressing poverty.